EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Gritstone Bio's enterprise value is €126.97 Mil.
Gritstone Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €0.78 Mil. Therefore, Gritstone Bio's EV-to-Revenue for today is 162.98.
The historical rank and industry rank for Gritstone Bio's EV-to-Revenue or its related term are showing as below:
STU:2JQ'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.11 Med: 34.04 Max: 1906.37
Current: 163.9
During the past 8 years, the highest EV-to-Revenue of Gritstone Bio was 1906.37. The lowest was 1.11. And the median was 34.04.
STU:2JQ's EV-to-Revenue is ranked worse than 87.38% of 1038
companies
in the Biotechnology industry
Industry Median: 8.075
vs STU:2JQ: 163.90
As of today (2024-06-04), Gritstone Bio's stock price is €0.6955.
Gritstone Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.01. Therefore, Gritstone Bio's PS Ratio for today is 115.92.
Gritstone Bio EV-to-Revenue Historical Data
The historical data trend for Gritstone Bio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Gritstone Bio's EV-to-Revenue
For the Biotechnology subindustry, Gritstone Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gritstone Bio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gritstone Bio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Gritstone Bio's EV-to-Revenue falls into.
Gritstone Bio's current Enterprise Value is €126.97 Mil.
Gritstone Bio's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gritstone Bio's share price for today is €0.6955.
Gritstone Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gritstone Bio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Gritstone Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, BiSAb, among others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:2JQ has been successfully added to your 